These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 2979807)

  • 1. Cellular immune mechanisms in the pathogenesis of Crohn's disease.
    James SP
    In Vivo; 1988; 2(1):1-7. PubMed ID: 2979807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune mechanisms in chronic inflammatory bowel disease.
    Braegger CP; MacDonald TT
    Ann Allergy; 1994 Feb; 72(2):135-41. PubMed ID: 8109803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5.
    Fuss IJ; Neurath M; Boirivant M; Klein JS; de la Motte C; Strong SA; Fiocchi C; Strober W
    J Immunol; 1996 Aug; 157(3):1261-70. PubMed ID: 8757634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunohistological study of T-lymphocytes (total and helper) and B-lymphocytes of the colonic mucosa in children with Crohn's disease and non-specific ulcerative colitis].
    Rodrigues M; Zerbini MC; Barbieri D
    Arq Gastroenterol; 1998; 35(3):223-36. PubMed ID: 10029869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestinal and peripheral blood lymphocyte subpopulations in Crohn's disease.
    Cagigas J; Echevarría S; Casafont F; Lozano JL; Rodríguez de Lope C; Pons Romero F
    Allergol Immunopathol (Madr); 1987; 15(3):133-6. PubMed ID: 3499061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Activation of the major omentum-associated lymphoid tissue in Crohn disease].
    Schreiber S; Gehrckens A; Raedler A
    Zentralbl Chir; 1995; 120(2):135-44. PubMed ID: 7709665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of intestinal immune system by dietary fat intake: relevance to Crohn's disease.
    Miura S; Tsuzuki Y; Hokari R; Ishii H
    J Gastroenterol Hepatol; 1998 Dec; 13(12):1183-90. PubMed ID: 9918423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type 1 T-helper cell predominance and interleukin-12 expression in the gut of patients with Crohn's disease.
    Parronchi P; Romagnani P; Annunziato F; Sampognaro S; Becchio A; Giannarini L; Maggi E; Pupilli C; Tonelli F; Romagnani S
    Am J Pathol; 1997 Mar; 150(3):823-32. PubMed ID: 9060820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of Crohn's disease using Colibiogen. Cellular reactions of the immune system in patients with Crohn's disease].
    Auer IO; Röder A; Mittelstaedt A
    Fortschr Med; 1985 Dec; 103(46):1076-80. PubMed ID: 2935464
    [No Abstract]   [Full Text] [Related]  

  • 10. Expression of costimulatory molecules B7-1 and B7-2 in macrophages and granulomas of Crohn's disease: demonstration of cell-to-cell contact with T lymphocytes.
    Hara J; Ohtani H; Matsumoto T; Nakamura S; Kitano A; Arakawa T; Nagura H; Kobayashi K
    Lab Invest; 1997 Aug; 77(2):175-84. PubMed ID: 9274860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease.
    Sartor RB
    Gastroenterol Clin North Am; 1995 Sep; 24(3):475-507. PubMed ID: 8809232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dyspeptic macrophage 30 years later: an update in the pathogenesis of Crohn's disease.
    Caprilli R; Frieri G
    Dig Liver Dis; 2009 Feb; 41(2):166-8. PubMed ID: 19026604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased lamina propria effector cell responsiveness to interleukin-10 in ileal Crohn's disease.
    Colpaert S; Vanstraelen K; Liu Z; Penninckx F; Geboes K; Rutgeerts P; Ceuppens J
    Clin Immunol; 2002 Jan; 102(1):68-76. PubMed ID: 11781069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease.
    Brand S
    Gut; 2009 Aug; 58(8):1152-67. PubMed ID: 19592695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis.
    Sartor RB
    Nat Clin Pract Gastroenterol Hepatol; 2006 Jul; 3(7):390-407. PubMed ID: 16819502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of the novel Th17 cytokine IL-26 in intestinal inflammation.
    Dambacher J; Beigel F; Zitzmann K; De Toni EN; Göke B; Diepolder HM; Auernhammer CJ; Brand S
    Gut; 2009 Sep; 58(9):1207-17. PubMed ID: 18483078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of the CD2 pathway in lamina propria T cells up-regulates functionally active AP-1 binding to the IL-2 promoter, resulting in messenger RNA transcription and IL-2 secretion.
    Gonsky R; Deem RL; Hughes CC; Targan SR
    J Immunol; 1998 May; 160(10):4914-22. PubMed ID: 9590239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [T-cell immunodeficiency and the status of the reparative processes in patients with Crohn's disease of the large intestine].
    Kucher ND; Peshko AV; Radolitskiĭ SE; Zhel'man VA
    Vrach Delo; 1990 Sep; (9):55-7. PubMed ID: 2284771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological studies on Crohn's disease. II. Lack of evidence for humoral and cellular dysfunctions.
    Fujita K; Okabe N; Yao T
    J Clin Lab Immunol; 1985 Mar; 16(3):155-61. PubMed ID: 3162025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD40 and CD86 upregulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel diseases.
    Vuckovic S; Florin TH; Khalil D; Zhang MF; Patel K; Hamilton I; Hart DN
    Am J Gastroenterol; 2001 Oct; 96(10):2946-56. PubMed ID: 11693331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.